Hearing impairment (Deafness)

Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 7/December/2017, 8.33 am
Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 7/December/2017, 8.33 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related…

read more

Natural product-based therapy for Deafness: A therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 4/December/2017, 11.04 pm
Natural product-based therapy for Deafness: A therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 4/December/2017, 11.04 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5),…

read more

Molecular therapy for Deafness: A therapeutic mix encompassing Paroxetine, Cholecalciferol, Ajoene and DIM (PCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 3/December/2017, 10.26 pm
Molecular therapy for Deafness: A therapeutic mix encompassing Paroxetine, Cholecalciferol, Ajoene and DIM (PCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 3/December/2017, 10.26 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: A therapeutic mix encompassing Paroxetine, Cholecalciferol, Ajoene and DIM (PCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents…

read more

Molecular therapy for Deafness: a therapeutic mix encompassing Aripiprazole, Cholecalciferol, Ajoene and DIM (ACAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 29/November/2017, 11.40 pm
Molecular therapy for Deafness: a therapeutic mix encompassing Aripiprazole, Cholecalciferol, Ajoene and DIM (ACAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 29/November/2017, 11.40 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: a therapeutic mix encompassing Aripiprazole, Cholecalciferol, Ajoene and DIM (ACAD)  increases the expression of ATG5 (Autophagy-related 5),…

read more

Molecular therapy for Deafness: A therapeutic mix encompassing Chlorprothixene, Cholecalciferol, Ajoene and DIM (CECAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 27/November/2017, 10.17 am
Molecular therapy for Deafness: A therapeutic mix encompassing Chlorprothixene, Cholecalciferol, Ajoene and DIM (CECAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 27/November/2017, 10.17 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: A therapeutic mix encompassing Chlorprothixene, Cholecalciferol, Ajoene and DIM (CECAD)  increases the expression of ATG5 (Autophagy-related 5),…

read more

Molecular therapy for Deafness: a therapeutic mix encompassing Imipramine, Cholecalciferol, Ajoene and DIM (ICAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 19/November/2017, 11.58 pm
Molecular therapy for Deafness: a therapeutic mix encompassing Imipramine, Cholecalciferol, Ajoene and DIM (ICAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 19/November/2017, 11.58 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Deafness: a therapeutic mix encompassing Imipramine, Cholecalciferol, Ajoene and DIM (ICAD)  increases the expression of ATG5 (Autophagy-related 5), prevents…

read more
Start Typing